Glipizide - PubMed


Ricardo Correa 1 ,

Article Images

Book

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.

.

Affiliations

Free Books & Documents

Book

Glipizide

Ricardo Correa et al.

Free Books & Documents

Excerpt

Glipizide is a second-generation sulfonylurea that is FDA-approved for the treatment of adults with diabetes mellitus type 2. It is administered as an adjunct to diet and exercise. It can be combined with metformin to reach goal HbA1c in patients with not adequate metabolic control in 3 months, despite compliance with diet, exercise, and medication. This activity will highlight the indications, mechanism of action, contraindications, adverse event profile, and potential toxicity of glipizide pertinent for members of the interprofessional team in the management care of patients with diabetes using glipizide.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Ricardo Correa declares no relevant financial relationships with ineligible companies.

Disclosure: Bryan Quintanilla Rodriguez declares no relevant financial relationships with ineligible companies.

Disclosure: Thomas Nappe declares no relevant financial relationships with ineligible companies.

Similar articles

References

    1. Costello RA, Nicolas S, Shivkumar A. StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2023. Jul 12, Sulfonylureas. - PubMed
    1. Saharan P, Bahmani K, Saharan SP. Preparation, Optimization and In vitro Evaluation of Glipizide Nanoparticles Integrated with Eudragit RS-100. Pharm Nanotechnol. 2019;7(1):72-85. - PMC - PubMed
    1. Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. PLoS Med. 2019 Mar;16(3):e1002763. - PMC - PubMed
    1. Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M, Cass A, Hawley CM, Pilmore H, Badve SV, Perkovic V, Zoungas S. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. - PMC - PubMed
    1. Drugs and Lactation Database (LactMed®) [Internet] National Institute of Child Health and Human Development; Bethesda (MD): 2021. Jan 18, Glipizide. - PubMed

Publication types